Stefan Hemmerich, PhD
Y's Therapeutics, Inc.
4
0
2
N/A
0
0
Research Impact
N/A
Research impact score
0
Total publications
0
Published trial results
0
Total citations
Drug Portfolio
Analytics
Trial Phases
Trial Status
Role Distribution
Activity Timeline
Clinical Trials (4)
Research Network
Collaboration Network
Research Areas & Affiliations
Affiliations
Similar Key Opinion Leaders
Discover other key opinion leaders with similar research profiles, therapeutic areas, and collaboration networks.
Art Wheeler, MD
Cumberland Pharmaceuticals
Shared therapeutic areas:
Giuseppe Remuzzi, MD
A.O. Ospedale Papa Giovanni XXIII
Shared therapeutic areas:
Marc Moss, MD
University of Colorado, Denver
Shared therapeutic areas:
John Flaherty, PharmD
Gilead Sciences
Shared therapeutic areas:
Pierce Chow, MD, PhD
National Cancer Centre, Singapore
Shared therapeutic areas:
Jeong Min Lee, MD
Seoul National University Hospital
Shared therapeutic areas:
Xiaolong Qi, MD
LanZhou University
Shared therapeutic areas:
Julien Aniort
University Hospital, Clermont-Ferrand
Shared therapeutic areas:
Colleen M Hadigan, M.D.
National Institute of Allergy and Infectious Diseases (NIAID)
Shared therapeutic areas:
Averell Sherker, MD
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Shared therapeutic areas:
Publications (0)
No publications found for this investigator.
Clinical Trials (4)
Showing 4 of 4 trials
YSPSL for Prevention of Delayed Graft Function Part B
YSPSL for Prevention of Delayed Graft Function in Cadaveric Liver Transplantation
YSPSL for Prevention of Ischemic Reperfusion Injury in Patients Undergoing Cadaveric Orthotopic Liver Transplantation
All 4 trials loaded